This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
September 27-30, 2022
Boston Convention and Exhibition CenterBoston, MA

Adam Ross
Product Manager at Halo Labs, USA


Adam obtained his PhD in the Zarbalis Lab at the University of California, Davis focusing on signaling networks in craniofacial and neurodevelopment. He went on to a postdoc in the Cheyette Lab at the University of California, San Francisco focusing on Wnt signaling pathway disruptions in developmental psychiatric diseases including schizophrenia and autism. Adam then joined ASC Therapeutics as an R&D scientist working on AAV therapeutics for Hemophilia in cells and mice leading to a successful IND filing. Adam joined Halo Labs in January of 2020 as an Field Application Scientist before recently moving into the role of Product Manager.

Agenda Sessions

  • Counting, Sizing, Imaging, and Identifying AAV and Cell Therapy Product Aggregates